Argenica Therapeutics Limited (ASX:AGN)
Australia · Delayed Price · Currency is AUD 0.1720
+0.0220 (14.67%)
May 8, 2026, 3:58 PM AEST
Argenica Therapeutics Market Cap
Argenica Therapeutics has a market cap or net worth of 22.48 million as of May 8, 2026. Its market cap has decreased by -75.11% in one year.
Market Cap
22.48M
Enterprise Value
17.44M
Revenue
1.01M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.17
Market Cap Chart
Since June 11, 2021, Argenica Therapeutics's market cap has increased from 19.02M to 22.48M, an increase of 18.16%. That is a compound annual growth rate of 3.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 22.48M | -40.68% |
| Dec 31, 2025 | 37.89M | -53.04% |
| Dec 31, 2024 | 80.70M | 59.59% |
| Dec 29, 2023 | 50.57M | 29.28% |
| Dec 30, 2022 | 39.12M | -35.98% |
| Dec 31, 2021 | 61.10M | 221.15% |
| Jun 11, 2021 | 19.02M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Avecho Biotechnology | 47.76M |
| Imugene | 42.35M |
| NeuroScientific Biopharmaceuticals | 33.26M |
| EZZ Life Science Holdings | 29.42M |
| Proteomics International Laboratories | 28.91M |
| Algorae Pharmaceuticals | 26.30M |
| Noxopharm | 21.51M |
| Patrys | 20.00M |